Brain creatine for predicting clinical course in white matter disorders

2020 ◽  
Vol 45 ◽  
pp. 102441
Author(s):  
Sergej M. Ostojic
2017 ◽  
Vol 134 (3) ◽  
pp. 329-330 ◽  
Author(s):  
Marianna Bugiani ◽  
Marjo S. van der Knaap

2020 ◽  
Vol 7 (1) ◽  
pp. 144-152 ◽  
Author(s):  
Guy Helman ◽  
Bryan R. Lajoie ◽  
Joanna Crawford ◽  
Asako Takanohashi ◽  
Marzena Walkiewicz ◽  
...  

2018 ◽  
Vol 20 ◽  
pp. 84-92 ◽  
Author(s):  
Parayil Sankaran Bindu ◽  
Kothari Sonam ◽  
Shwetha Chiplunkar ◽  
Periyasamy Govindaraj ◽  
Madhu Nagappa ◽  
...  

Author(s):  
Ji Y. Chong ◽  
Michael P. Lerario

Cognitive impairment is common following stroke. The clinical course and presentation are variable in vascular dementia, but the diagnosis can often be tied to recent vascular events or to progressive white matter lesions on MRI. Because there is considerable overlap between patients with vascular and Alzheimer’s type dementia, both acetylcholinesterase inhibitors and memantine have been tried off-label to treat the cognitive symptoms of vascular dementia with mixed results.


Author(s):  
Ji Y. Chong ◽  
Michael P. Lerario

Posterior reversible encephalopathy syndrome is a clinical–radiographic syndrome of progressive headaches, blurred vision, confusion, and seizures in the setting of vasogenic edema on brain imaging, which is often localized to the posterior white matter. The symptoms are classically triggered by severe hypertension, pregnancy and the puerperium, or exposure to immunosuppressive medications. The symptoms can be reversible if the offending etiology is quickly removed, but permanent deficits can remain if strokes or hemorrhage complicate the clinical course.


2020 ◽  
Vol 88 (2) ◽  
pp. 264-273 ◽  
Author(s):  
Adeline Vanderver ◽  
Geneviève Bernard ◽  
Guy Helman ◽  
Omar Sherbini ◽  
Ryan Boeck ◽  
...  

2010 ◽  
Vol 7 (2) ◽  
pp. 159-164 ◽  
Author(s):  
Hauke B Werner ◽  
Olaf Jahn

Sign in / Sign up

Export Citation Format

Share Document